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Recent advances in the fields of electronics and microfabrication techniques have led to the 36 
development of implantable medical devices for use within the field of precision medicine. 37 
Monitoring visceral surface tissue O2 tension (ptO2) by means of an implantable sensor is 38 
potentially useful in many clinical situations, including the peri-operative management of 39 
patients undergoing intestinal resection and anastomosis. This concept could provide a 40 
means by which treatment could be tailored to individual patients. This study describes the 41 
in vivo validation of a novel miniaturised electrochemical O2 sensor to provide real-time 42 
data on intestinal ptO2. A single O2 sensor was placed onto the serosal surface of the small 43 
intestine of anaesthetised rats that were exposed to ischaemic (superior mesenteric artery 44 
occlusion) and hypoxaemic (alterations in inspired fractional O2 concentrations) insults. 45 
Control experiments demonstrated that the sensors function and remain stable in an in vivo 46 
environment. Intestinal ptO2 decreased following superior mesenteric artery occlusion and 47 
with reductions in inspired O2 concentrations. These results were reversible after reinstating 48 
blood flow or increasing inspired O2 concentrations. We have successfully developed an 49 
anaesthetised rat intestinal ischaemic and hypoxic model for validation of a miniaturised O2 50 
sensor to provide real-time measurement of intestinal ptO2. Our results support further 51 
validation of the sensors in physiological conditions using a large animal model to provide 52 
evidence of their use in clinical applications where monitoring visceral surface tissue O2 53 
tension is important. 54 
New and Noteworthy 55 
This is the first report of real-time continuous in vivo recordings made using a 56 
microfabricated Clark-type O2 sensor for measuring intestinal oxygen tension. Using a 57 
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developed rodent model, we have validated this sensors ability to accurately measure 58 
dynamic and reversible changes in intestinal oxygenation that occurred through ischaemic 59 
and hypoxaemic insults. Continuous monitoring of local intestinal oxygenation could have 60 
value in the post-operative monitoring of patients having undergone intestinal surgery. 61 
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Miniaturised electrochemical oxygen sensor, Superior mesenteric artery occlusion 64 




Precision medicine is beginning to play important roles in the prevention, investigation and 66 
treatment of a range of diseases as it enables individual patient variability to be considered. 67 
Precision medicine may be integrated into standard clinical practices in different ways, 68 
however, recent advances in the fields of electronics and microfabrication techniques have 69 
led to interest in the use of implantable medical devices for disease diagnosis, treatment 70 
and monitoring. Pre-clinical research using in vivo murine studies have already shown that 71 
implantable devices can detect tumour secreted biomarkers (8) or release 72 
chemotherapeutic drugs directly within tumours (29). The biocompatibility and 73 
biofunctionality of implantable devices in a range of diseases has also been shown in many 74 
studies using in vivo models, providing substantial evidence of their increasing potential for 75 
clinical applications (15). 76 
One such implantable medical device is being developed through the Implantable 77 
Microsystems for Personalised Anti-Cancer Therapy (IMPACT) programme at the University 78 
of Edinburgh (27). This project has developed a novel miniaturised implantable O2 sensor on 79 
a silicon chip designed to monitor intra-tumoural O2 levels. The design is based on a Clark 80 
electrode for the electrochemical detection of O2 which is connected by a lead to external 81 
instrumentation. Hypoxic tumour areas are more resistant to radio and chemotherapy, 82 
therefore identifying them by means of an implantable sensor may enable these regions to 83 
be targeted more efficiently. However, the use of this sensor may not be restricted to 84 
cancer patients and may have additional applications in which monitoring visceral surface 85 
tissue O2 tension (ptO2) is clinically important. One potential situation where assessment of 86 
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tissue perfusion would be advantageous is in the peri-operative management of patients 87 
undergoing intestinal surgery. 88 
Intestinal resection and anastomosis is a commonly performed abdominal operation for a 89 
variety of benign and malignant diseases. The procedure involves removal (resection) of a 90 
segment of intestine with the subsequent re-joining (anastomosis) of the intestinal ends in a 91 
manner that optimises healing and restores mural and luminal integrity. However, if the 92 
anastomosis fails to heal and a leak develops, patients suffer a significant increase in 93 
morbidity (17, 23, 28) and mortality (9). Leak rates can be as high as 24% for surgery 94 
performed in the distal rectum; however, overall leak incidence is generally accepted to be 95 
approximately 6-7% (6, 21). The aetiology of an anastomotic leak is multifactorial; however, 96 
blood flow disruption, leading to compromised tissue perfusion and decreased oxygenation 97 
is known to affect anastomotic healing through the development of peri-anastomotic 98 
necrosis (38). Surgeons typically asses intra-operative intestinal perfusion through 99 
macroscopic tissue appraisal; however, this subjective technique is unable to predict the risk 100 
of a leak occurring. It is suggested that objective measurements of tissue perfusion at the 101 
anastomosis can aid the identification of anastomotic sites at increased risk of leakage (24). 102 
Methods used to assess tissue perfusion (visible light and near infrared spectroscopy and 103 
laser fluorescence angiography) (13, 19) and oxygen tensions (scanning laser Doppler 104 
flowmetry and wireless hand held pulse oximeters) (7, 38) have been shown to help predict 105 
the occurrence of a leak. Visible light spectroscopy has also been shown to be compatible 106 
with endoscopic procedures (5, 13, 25). Currently there is one clinical trial underway 107 
assessing whether the intra-operative measurement of anastomotic perfusion using a 108 
fluorescent dye (indocyanine green) and near-infrared laparoscopy can minimise the 109 
occurrence of leaks compared with conventional white-light laparoscopy (3). Pre-clinical (26, 110 
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39) and clinical (40, 41) studies have also shown that Clark O2 sensors can not only measure 111 
intestinal ptO2, but also predict the occurrence of an anastomotic leak. These studies used 112 
O2 sensors consisting of a platinum cathode and sliver anode, which were used to measure 113 
intra-operative intestinal ptO2. Intra-operative measurements were only possible due to the 114 
large size of the electrodes used in the pre-clinical studies (62x7mm, intestinal contact 115 
surface 2mm) (39) and because hand held devices were used in both clinical studies.  116 
Unfortunately, none of these techniques are routinely used by clinicians and are only 117 
applicable to intra-operative use; they cannot be left in situ as a means of real-time, 118 
continuous, post-operative monitoring. The development of a miniaturised implantable 119 
device for the continuous intra- and post-operative monitoring of intestinal ptO2 could 120 
provide an additional means by which anastomotic healing could be monitored, thereby 121 
providing a means by which peri-operative patient treatment could optimised. In this study 122 
we describe the development and use of an anaesthetised rat intestinal ischaemic and 123 
hypoxic model for validation of the IMPACT O2 sensor to provide real-time measurement of 124 
intestinal ptO2. 125 
Materials and Methods 126 
Studies were undertaken under a UK Home Office Project Licence in accordance with the 127 
Animals (Scientific Procedures) Act 1986 and with approval from the University College 128 
London Animal Ethics Committee. Male Wistar rats (Charles River Laboratories, Margate, 129 
UK) of approximately 400 g body weight were used in all experiments (n>4/treatment 130 
group). Prior to instrumentation, the rats were acclimatised for at least 1 week and housed 131 
in cages of 4 on an alternating 12 h light/dark cycle with ad libitum access to food and 132 
water. 133 
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Rats were anaesthetised using isoflurane (Abbott, Maidenhead, UK) delivered in room air 134 
(5% for induction, 2% for surgical procedures and 1.5% for maintenance). Rats were placed 135 
on a heated mat to maintain rectal temperature between 36.5–37.5oC, which was 136 
continuously monitored using a temperature sensor (Harvard Apparatus, Cambridge, UK) 137 
inserted into the rectum. Placement of arterial and venous lines was performed as reported 138 
previously (10) (Fig.1). The arterial line was subsequently connected to a pressure 139 
transducer system (Powerlab and Chart 5 acquisition software, AD Instruments, Chalgrove, 140 
UK) for continuous monitoring and recording of mean arterial blood pressure and heart 141 
rate. The arterial line was also used for intermittent blood sampling; when required, 0.1 ml 142 
of arterial blood was taken into heparinised capillary tubes for blood-gas analysis (ABL90 143 
Analyser; Radiometer, Copenhagen, Denmark). The venous line was used for administration 144 
of fluids; all animals received a continuous infusion of 10–20 ml/kg/hr compound sodium 145 
lactate (Baxter, Thetford, UK) to maintain mean arterial blood pressure at approximately 146 
100 mmHg. A tracheostomy was created using 2.08 mm external diameter polythene tubing 147 
(Portex Ltd, Hythe, UK); this was attached to a T-piece to secure the airway, maintain 148 
anaesthesia and to allow alterations in the inspired fractional O2 concentration (FiO2). 149 




Figure 1. Intra-operative photographs depicting placement of central venous (jugular) and 151 
arterial (carotid) lines. a) A 2 cm ventral cervical skin incision is made. b&c) Cervical 152 
dissection is performed for identification and mobilisation of the right jugular vein. d) One 153 
untied suture is placed distally around the jugular vein and a second is placed proximally 154 
and tied securely, leaving approximately 1 cm of vein between the 2 sutures. e) A venotomy 155 
is created just distal to the proximal suture; the cannula is inserted and advanced into the 156 
vein approximately 2-3 cm before tying the distal suture around the vein and cannula. f) 157 
Cervical dissection is performed for identification of the left carotid artery and its isolation 158 
from the vagus nerve. g) One untied suture is placed distally around the carotid artery and a 159 
second is placed proximally and tied securely leaving approximately 1.5 cm of artery 160 
between the 2 sutures. A small clamp is added just proximal to the distal suture before 161 
placing a third untied suture. h) An arteriotomy is created between the 2 sutures and the 162 
cannula is inserted and advanced up to the clamp. i) The third suture is tied loosely over the 163 
cannula and the clamp is removed. j) The cannula is advanced a further 2 cm before tying 164 
the distal suture around the artery and cannula. Both vessels were cannulated using 0.96 165 
mm outside diameter PVC tubing (Scientific Commodities Inc., Lake Havasu City, AZ, USA) 166 
and secured in place with 5-0 silk (Ethicon, UK). 167 
One control group (to assess sensor longevity and baseline drift) and two treatment groups 168 
(either superior mesenteric artery occlusion, or manipulation of FiO2 and circulating blood 169 
volume) were used to assess whether the sensor could detect changes in intestinal 170 
oxygenation following local or systemic cardiorespiratory insults (Fig. 2). A ventral midline 171 
celiotomy was performed on all animals extending from the pubis to the manubrium and a 172 
temporary cystotomy was created by making a small stab incision at the apex of the 173 
bladder, which was then cannulated with 1.57 mm external diameter polythene tubing 174 
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(Portex Ltd, Hythe, UK) and sutured in place. To allow access to the abdominal vasculature 175 
and placement of the sensor, the caecum and small intestine were exteriorised to the left 176 
side on the animal, wrapped in cling film (to reduce evaporative fluid and convective heat 177 
loss) and kept moist with regular topical applications of saline. The O2 sensor was placed on 178 
the antimesenteric serosal surface of a proximal section of small intestine. The active area 179 
of the sensor was kept moist and placed at the midpoint between small serosal blood 180 
vessels (Fig. 3). The sensor lead was temporarily attached to the serosal surface of the 181 
bowel using tissue adhesive (Vetbond, 3M, Bracknell, UK). Following instrumentation, all 182 
animals were allowed a period of stabilisation of at least 30 min to achieve stable baseline 183 
physiological variables. Continuous sensor readings were made throughout each 184 
experiment, commencing after the initial stabilisation period and continuing for 15 min 185 
following confirmation of death post-euthanasia. All animals were euthanised with 186 
intravenous sodium pentobarbitone (Pentoject; Animalcare, York, UK). 187 
 188 
Figure 2. Outline of experimental protocols and interventions. Protocol 1: Control animals 189 
with no interventions. Protocol 2: Superior mesenteric artery occlusion. Protocol 3: 190 
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Alterations in FiO2, haemorrhage and autotransfusion (resuscitation). Instrumentation 191 
encompassed: anaesthesia induction, surgical preparation, placement of arterial and venous 192 
lines and celiotomy. The sensor was placed on the serosal surface of the small intestine 193 
approximately half way through the stabilisation period. Continuous sensor readings were 194 
commenced following the achievement of stable baseline physiological variables and 195 
continued for 15 min following confirmation of death post-euthanasia. 196 
 197 
Figure 3. Sensor picture and intra-operative photographs depicting intestinal placement of 198 
the sensor. a) Macroscopic image of the IMPACT miniaturised O2 sensor. b) Intra-operative 199 
sensor placement on the serosal surface of a section of small intestine. 200 
Oxygen Sensor Recordings 201 
The IMPACT O2 sensor contains a complete miniaturised three-electrode cell, with platinum 202 
working and counter electrodes, and a silver/silver chloride reference electrode. Nafion was 203 
used to cover the electrode surfaces to reduce electrode biofouling and improve sensor 204 
lifetime. Electrodes were fabricated on silicon wafers using conventional microfabrication 205 
techniques, and diced into 2.0 mm x 3.0 mm chips, each of which carried a single sensor 206 
(Marland et al., manuscript submitted). Chips were wire bonded to a 1.7 mm x 200 mm long 207 
lead, and the chip was sealed in biocompatible epoxy resin giving an overall sensor size of 208 
approximately 2.8 mm x 5.0 mm x 1.4 mm (width x length x height), with a clear window 209 
over the central active area to permit sensor access to the tissue environment. Following 210 
intestinal placement/implantation, the sensor lead was connected to an EmStat3 Blue 211 
potentiostat (PalmSens BV, Houten, Netherlands). Periodic O2 measurements were 212 
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performed using chronoamperometry at -0.5 V (versus the on-chip Ag/AgCl reference 213 
electrode) for 20 s, followed by a rest period of 20 s, repeated continuously for the duration 214 
of the experiment. The working electrode current over the final 5 s of each 215 
chronoamperometry recording was averaged using MATLAB R2017a (MathWorks, Natick, 216 
MA, USA) to derive the mean current. We have previously shown that the measured current 217 
magnitude is proportional to local pO2 at the sensor surface in saline (Marland et al., 218 
manuscript submitted). However, since there may be small environmental differences 219 
between saline and tissue that could affect the slope of the sensor response in vivo, we 220 
chose to directly quantify its electrode current in this study. 221 
Protocol 1: Control group 222 
The control group of animals consisted only of continuous sensor readings taken for 165 223 
min. These animals were sham operated, receiving only a ventral midline celiotomy (as 224 
described in the previous section) for sensor placement with no superior mesenteric artery 225 
(SMA) occlusions or manipulations of FiO2 or circulating blood volume being performed 226 
(i.e.no physiological challenges were performed on these instrumented animals). Arterial 227 
blood samples were obtained immediately prior to the start of continuous sensor readings, 228 
every hour thereafter and then just prior to euthanasia. 229 
Protocol 2: Intestinal tissue responses to temporary superior mesenteric artery occlusion 230 
For temporary SMA occlusion, the vessel was first identified originating from the left side of 231 
the aorta at the level of the right renal vein joining the caudal vena cava. The SMA was 232 
dissected free from surrounding soft tissue and its associated vein as close to its aortic origin 233 
as possible. A loose suture of 5-0 silk (Ethicon, UK) was placed round the artery for ease of 234 
location and to allow gentle traction to aid its temporary and reversible mechanical 235 
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occlusion. Following its isolation, the vessel was repeatedly occluded with the use of a 236 
haemostatic clamp (Fine Science Tools, Linton, UK). Each occlusion was performed for 5 min 237 
with a 10 min reperfusion period between occlusions. Vessel occlusion was confirmed by 238 
loss of pulsations in the mesenteric arteries and intestinal pallor. A hyperaemic flush and the 239 
presence of mesenteric arterial pulsations were evident following removal of the 240 
haemostatic clamp. Arterial blood samples were obtained immediately prior to the start of 241 
continuous sensor readings and just before euthanasia. 242 
Protocol 3: Intestinal tissue responses to alterations in inspired oxygen concentrations, 243 
progressive haemorrhage and autotransfusion 244 
FiO2 (1.0, 0.21, 0.1) was varied at 15 min intervals and delivered through a flowmeter via the 245 
isoflurane vaporiser to maintain adequate anaesthesia. The protocol for varying FiO2 was: 246 
0.21 for 15 min, 0.1 for 15 min (inducing hypoxaemia), 0.21 for 15 min, 1.0 for 15 min 247 
(inducing hyperoxaemia) before returning to 0.21 for 15 min. Arterial blood samples were 248 
taken at the end of each FiO2 alteration. 249 
Following completion of the FiO2 modifications, progressive haemorrhage was achieved by 250 
withdrawing 15% of the animals circulating blood volume (estimated based on 70 ml/kg 251 
body weight) over 5 min. The animal was allowed to stabilise for 10 min before a further 252 
15% circulating blood volume was removed. The exsanguinated blood was collected in a 253 
heparinised syringe and maintained at 37oC. Autotransfusion was performed by 254 
administering the exsanguinated blood intravenously to the animal over 10 min. Arterial 255 
blood samples were taken at the end of each haemorrhage procedure and just before 256 
euthanasia. 257 
Statistical Analysis 258 
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Data was confirmed as normally distributed using the Shapiro-Wilk test and subsequently 259 
analysed with parametric tests; one-way ANOVA with Holm-Šídák multiple comparisons test 260 
was used to test for differences between groups; P values <0.05 were deemed statistically 261 
significant. Data were expressed as mean ± standard error of the mean (SEM). Statistical 262 
analyses were performed using Prism 7 (GraphPad Software, San Diego, CA, USA). 263 
Results 264 
Sensor readings remained stable in control animals 265 
For assessment of sensor stability, we performed continuous sensor readings in 266 
instrumented rats which were not subjected to any physiological interventions (n=3). These 267 
control experiments were of a duration that encompassed the longest experimental 268 
protocol. The negative currents generated in the O2 sensors are proportional to ptO2, with 269 
more negative values indicating greater O2 partial pressures. The measured currents were 270 
stable over 165 min, with mean values ranging from -1.14 ± 0.03 nA at 15 min to -1.44 ± 271 
0.15 nA at 135 min (p=0.7244) (Fig. 4a). 272 
To assess the stability of the rats during anaesthesia, physiological data including core 273 
temperature (CT), heart rate (HR), respiratory rate (RR) and mean arterial blood pressure 274 
(MAP) plus intermittent blood-gas and biochemistry samples were evaluated. All 275 
physiological data, blood-gas analysis and electrolytes remained stable; only blood glucose 276 
levels decreased slightly towards the end of the procedure. Although this reduction was not 277 
statistically significant (p= 0.9304) it is consistent with the fasting state and metabolic 278 
demands of the rat during anaesthesia (Fig 4b). The physiological data obtained, combined 279 
with arterial blood analysis, provided evidence that the rats were able to cope with the 280 
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physiological demands from general anaesthesia for the duration of our experimental 281 
protocols. These results are in accordance with other previous studies (11). 282 
 283 
Figure 4. Sensor readings and physiological data obtained from control animals (Protocol 284 
1). a) Current generated at the working electrode of the sensor during continuous sensor 285 
readings over a period of 165 min; results show mean current readings from the final 5 min 286 
of each 15 min period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 287 
expressed as mean ± SEM, n=3, p=0.7244). b) Physiological data obtained throughout the 288 
experimental period (Hb: haemoglobin; ABE: arterial base excess; SaO2: haemoglobin O2 289 
saturation; PaO2: arterial O2 partial pressure; PaCO2: arterial CO2 partial pressure; CT: core 290 
temperature; RR: respiratory rate; HR: heart rate). 291 
Oxygen current generated by the sensor rapidly decreased following occlusion of the 292 
superior mesenteric artery and was reversible upon reinstatement of blood flow 293 
To assess whether the sensor could detect changes in intestinal oxygenation through the 294 
generation of localised tissue ischaemia, we performed three cycles of temporary SMA 295 
occlusion followed by release in each rat (n=4) (Fig. 5a). After each occlusion, there was an 296 
almost immediate fall in sensor current from non-occluded readings of -1.85 ± 0.05 nA to 297 
occluded readings of -0.27 ± 0.08 nA. The decrease in current that occurred during each 298 
occlusion was statistically significant when compared to current values pre- and post-299 
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occlusion (p= 0.0082). The decrease in current during the occlusion quickly rose back to non-300 
occluded current levels following reinstatement of blood flow (Fig. 5b and Table I). 301 
Following euthanasia, sensor readings fell to the lowest recorded, measuring 0.04 ± 0.16 nA; 302 
this decrease was statistically significant when compared to non-occluded SMA currents (p= 303 
0.0025) (Fig. 5c). These results showed that the sensor could quickly, reliably and 304 
reproducibly detect transient intestinal ischaemia. 305 
 306 
Figure 5. Intra-operative photographs and sensor readings during temporary superior 307 
mesenteric artery occlusion (Protocol 2). ai) Identification of the SMA originating from the 308 
left side of the aorta at the level of the right renal vein joining the caudal vena cava; the 309 
vessel is robust and can withstand the manipulation required for isolation from its 310 
surrounding tissue and associated vein. aii) A Bulldog clamp was placed across the SMA for 311 
temporary occlusion. Note the intestinal pallor that was immediately evident upon 312 
occlusion. aiii) Following removal of the Bulldog clamp and reinstatement of blood flow, a 313 
hyperaemic flush was evident to the intestines. b) Representative graph showing current 314 
generated at the working electrode of the sensor during continuous sensor readings over a 315 
period of 70 min. Three cycles of 5 min occlusion followed by 10 min of reperfusion were 316 
performed in each animal before euthanasia. c) Combined analysis comparing current 317 
generated at the working electrode of the sensor during periods of SMA occlusion and 318 
intestinal reperfusion; results show mean current readings of the final 3 min of each 319 
occlusion period and final 5 min of each reperfusion period (one-way ANOVA with Holm-320 
Šídák multiple comparisons test; data expressed as mean ± SEM, n=4, **p≤0.01). 321 
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-1.73 ± 0.40 -0.41 ± 
0.24 
-1.85 ± 0.36 -0.28 ± 
0.27 
-1.84 ± 0.32 0.04 ± 0.16 
Table I. Current readings generated during each superior mesenteric artery occlusion and 322 
reperfusion period and euthanasia (n=4; mean ± SEM). 323 
Oxygen current generated by the sensor responded rapidly to alterations in inspired 324 
oxygen concentrations 325 
To assess whether the sensor could detect changes in intestinal oxygenation through 326 
alterations in FiO2 we performed sequential inspired O2 challenges varying from 0.1-1.0 327 
(n=5). With an FiO2 of 0.21 (breathing room air), the mean sensor current was -1.35 ± 0.06 328 
nA. When FiO2 was reduced to 0.1, the sensor current decreased by more than half, to -0.60 329 
± 0.10 nA. This decrease was statistically significant when compared to currents generated 330 
when breathing room air (p= 0.0396). The decrease in current occurred over 1-2 min and 331 
was maintained throughout the hypoxaemic challenge. Following restoration of FiO2 to 0.21, 332 
the current returned to baseline levels over a period of 1-2 min. Upon increasing inspired 333 
FiO2 to 1.0 the sensor current rose to -6.53 ± 0.46 nA, which was statistically significant 334 
when compared to currents generated with an FiO2 of 0.21 (p< 0.0001). This increase in 335 
current was again maintained throughout the FiO2 challenge. Returning FiO2 back to room 336 
air saw sensor currents return to baseline levels. Following euthanasia, sensor readings fell 337 
to the lowest recorded, measuring -0.08 ± 0.17 nA (Fig 6a). These results showed that the 338 
sensor could quickly, reliably and reproducibly detect changes in intestinal oxygenation 339 
following alterations in FiO2 (Fig 6b and Table II). 340 
Blood-gas analysis at the end of each FiO2 challenge showed the expected physiological 341 
alterations in arterial O2 partial pressure (PaO2) and haemoglobin O2 saturation (SaO2). Both 342 
variables decreased significantly at an FiO2 of 0.1, increased significantly at an FiO2 of 1.0 343 
Downloaded from www.physiology.org/journal/ajpgi at Univ of Strathclyde (130.159.082.179) on June 21, 2019.
17 
 
(more prominent with PaO2), and returned to baseline levels at 0.21. Total haemoglobin 344 
(Hb) concentration remained constant (Fig. 6c & d). 345 
 346 
Figure 6. Sensor readings and physiological data obtained from assessing intestinal tissue 347 
oxygenation following changes in inspired O2 concentrations (Protocol 3A). a) 348 
Representative graph showing current generated at the working electrode of the sensor 349 
during continuous sensor readings over a period of 150 min. 15 min blocks of each FiO2 350 
challenge were performed before beginning the removal of 30% of the circulating blood 351 
volume. b) Combined analysis comparing current generated at the working electrode of the 352 
sensor during each FiO2 challenge; results show mean current readings of the final 5 min of 353 
each 15 min period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 354 
expressed as mean ± SEM, n=5, ****p≤0.0001; *p≤0.05). c&d) Arterial O2 partial pressure, 355 
total haemoglobin and haemoglobin O2 saturation measured at end of each FiO2 challenge. 356 
 21% (1) 10% 21% (2) 100% 21% (3) Euthanasia 
Current (nA) -1.35 ± 0.18 -0.60 ± 0.10 -1.37 ± 0.12 -6.53 ± 0.46 -1.55 ± 0.20 -0.08 ± 0.17
Table II. Current readings generated during each FiO2 challenge and euthanasia (n=5; mean 357 
± SEM). 358 
No change in sensor current was identified following progressive haemorrhage 359 
Downloaded from www.physiology.org/journal/ajpgi at Univ of Strathclyde (130.159.082.179) on June 21, 2019.
18 
 
Following completion of FiO2 challenges, we assessed the ability of the sensor to detect 360 
changes in intestinal ptO2 following progressive withdrawal of 30% circulating blood volume 361 
(performed in 2x 15% removal periods) (n=5) (Fig 7a). Physiological data obtained 10 min 362 
after the end of each haemorrhage procedure showed the expected physiological response 363 
occurring from acute haemorrhage: HR, MAP and Hb concentration all showed a moderate 364 
decrease after 15% removal, which was even more pronounced after 30%; HR decreased 365 
from 405 ± 22 bpm to 348 ± 16 bpm, MAP decreased from 118 ± 12 mmHg to 56 ± 3 mmHg, 366 
and Hb decreased from 13.3 ± 0.6 g/dl to 11.4 ± 0.4 g/dl. All of these physiological 367 
parameters returned to baseline levels following autotransfusion (Fig. 7b & c). SaO2 368 
remained constant throughout each haemorrhage procedure. 369 
Despite these expected physiological responses to acute haemorrhage, only a small and 370 
non-significant decrease in sensor current was observed. Baseline measurements were -1.55 371 
± 0.20 nA; however, following 15% and 30% haemorrhage currents only decreased to -1.39 372 
± 0.13 nA and -1.33 ± 0.13 nA respectively. Following autotransfusion, no statistically 373 
significant changes in sensor current occurred, measuring -1.22 ± 0.14 nA at the end of the 374 
transfusion (Table III). 375 




Figure 7. Sensor readings and physiological data obtained from assessing intestinal tissue 377 
oxygenation following progressive haemorrhage and autotransfusion (Protocol 3B). a) 378 
Combined analysis comparing current generated at the working electrode of the sensor 379 
during the preceding 15 min baseline period at 21% O2 and the subsequent 2 cycles of 380 
removal of 15% circulating blood volume followed by autotransfusion; results show mean 381 
current readings of the final 5 min of each period (one-way ANOVA with Holm-Šídák’s 382 
multiple comparisons test; data expressed as mean ± SEM, n=5). b&c) Mean arterial blood 383 
pressure, heart rate, total haemoglobin and haemoglobin O2 saturation measured at end of 384 
each of intervention period (haem: haemorrhage; Resus: autotransfusion resuscitation). 385 
 Baseline 15% haemorrhage 30% haemorrhage Autotransfusion 
Current (nA) -1.55 ± 0.20 -1.39 ± 0.13 -1.33 ± 0.13 -1.22 ± 0.14 
Table III. Current readings generated during 21% FiO2, each haemorrhage procedure and 386 
autotransfusion (n=5; mean ± SEM). 387 
Discussion 388 
For validation and proof-of-concept that the IMPACT O2 sensor can provide real-time 389 
measurements of intestinal ptO2 we developed an in vivo intestinal ischaemic (SMA 390 
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occlusion) and hypoxic (changes in FiO2) model. Control experiments were first used to 391 
demonstrate that the rats could remain physiologically stable under general anaesthesia 392 
and that the sensors provided stable measurements. These experiments also allowed us to 393 
rule out potential effects of the tissue environment on sensor stability; the design and 394 
packaging of the IMPACT O2 sensor is likely to have minimised this potential problem. The 395 
outer protective coating is made from Nafion, an ionomer made by the addition of sulfonic 396 
acid groups to Teflon. Nafion membranes are commonly used in a variety of implantable 397 
devices due to the selectively of substances which diffuse through it. The pore size within 398 
the membrane is sufficiently small to exclude macromolecules such as proteins that may 399 
contaminate the electrode surface, while the presence of charged sulphonate groups leads 400 
to the electrostatic exclusion of small anions (34). 401 
Our sensors were placed onto the intestinal serosal surface and secured with tissue glue. 402 
This technique avoided the use of constant manual pressure on the sensor which could 403 
interfere with intestinal blood supply leading to alterations in ptO2 measurements (40). The 404 
tissue area from which the electrode measures ptO2 is related to electrode size, a matter 405 
which needs to be considered if Clark electrodes are used for clinical applications. The 406 
working electrode (where O2 is detected) of the IMPACT O2 sensor has a diameter of 50 µm. 407 
This small sensing area means the sensor will not significantly deplete tissue O2 levels, while 408 
also allowing for accurate sensor placement to specific areas by the surgeon. Use of multiple 409 
sensors would provide ptO2 readings from a larger area, which is advantageous for 410 
anastomotic surgery as sensors could be placed around the anastomotic circumference and 411 
at either side of the resection site, giving detailed peri-anastomotic ptO2 information. Such 412 
detailed information could not be achieved using a sensor with a large working area that 413 
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gives only mean ptO2 readings from multiple capillary beds, as is likely the case in the pre-414 
clinical and clinical studies using Clark electrodes described in the introduction. 415 
The SMA is the principal arterial supply to a large part of the gastrointestinal tract (from the 416 
lower part of the duodenum through to the proximal two-thirds of the transverse colon, and 417 
pancreas); its occlusion is the most direct way of causing intestinal ischaemia. Various SMA 418 
occlusion techniques have been documented in previous studies for the investigation of 419 
ischaemic intestinal insults, including ischaemia-reperfusion injuries (14, 22), cytokine 420 
production and bacteria/endotoxin translocation (16). In our study we performed 421 
temporary SMA ligation close to its aortic origin to ensure that no collateral circulation from 422 
any of its branches (inferior pancreaticoduodenal, intestinal, ileocolic, right and middle 423 
colic) could supply the region of small intestine of interest. Our results showed that within 424 
1-2 min following SMA occlusion the current generated by the sensor fell to almost 0 nA, 425 
indicating a fully hypoxic state. This fall in current will be related to ischaemia and utilisation 426 
of the residual available O2 by the tissues. Reperfusion of the intestine led to both visual 427 
changes in the tissue (hyperaemic flush and reoccurrence of mesenteric arterial pulsations) 428 
and a rapid raise in sensor current, indicating a return of normal oxygenation status to the 429 
intestine. This shows that the sensor reliably and reproducibly detects tissue hypoxia. 430 
Following confirmation that changes in intestinal ptO2 could be detected through ischaemic 431 
insults we determined if alterations in blood oxygenation, through changes in FiO2, could be 432 
detected. Arterial blood-gas analysis confirmed the expected physiological responses to FiO2 433 
challenges. Hypoxaemia caused a decrease in PaO2 and SaO2, whereas hyperoxaemia led to 434 
an increase in their levels. Sensor current readings mirrored these results which changed in 435 
Downloaded from www.physiology.org/journal/ajpgi at Univ of Strathclyde (130.159.082.179) on June 21, 2019.
22 
 
accordance with FiO2. Response times, as with ischaemia, were rapid, with the sensor giving 436 
stable currents 1-2 min after a FiO2 change. 437 
Although changes in intestinal ptO2 were detected though SMA occlusion and FiO2 438 
alterations, no such changes were evident with acute haemorrhage. The reductions in HR 439 
and BP following 30% removal of circulating blood volume are consistent with increased 440 
vagal activity and reduced sympathetic input (Bezold–Jarish-like reflex), resulting in a 441 
decrease in total peripheral resistance. Only with more profound reductions in circulating 442 
blood volume is HR likely to increase during haemorrhage, representing a transition from 443 
reversible to irreversible shock (37). Although a slight decrease in Hb concentration was 444 
noted with 30% haemorrhage, SaO2 levels remained consistent. Stable SaO2 levels were 445 
likely due to the haemorrhage procedures being performed using an FiO2 of 0.21. This level 446 
of SaO2 in combination with a decrease in peripheral resistance may have been sufficient to 447 
maintain intestinal ptO2, which could explain why no change in sensor currents were 448 
observed. 449 
One of the main advantages of our experiments over previous published studies is that they 450 
were designed not only to assess whether our sensor could detect a change in intestinal 451 
ptO2 following an initial physiological challenge, but also whether sensor readings could 452 
reverse to baseline levels upon removal of the challenge. Previous work has mainly reported 453 
results using individual measurements at specific time points (26, 39-41); the continuous 454 
recording of data performed in this study provided an opportunity to dynamically measure 455 
ptO2 changes before, during and after each challenge. Our results reproducibly showed that 456 
sensor currents returned to baseline levels following each challenge. 457 
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For any implantable medical device to gain clinical approval it must undergo 458 
biocompatibility evaluation to assess biofunctionality (performance) and biosafety (local and 459 
systemic tissue responses and the absence of carcinogenesis, mutagenesis and cytotoxicity) 460 
(4, 30, 36). Following implantation medical devices can lose functionality, largely due to 461 
biofouling (non-specific protein absorption) and the production of granulation and fibrous 462 
tissue around the implanted device (2). This process, known as the foreign body response 463 
(FBR), is composed of both acute and chronic inflammatory phases (2, 30, 31) and 464 
represents a clinical challenge in implantable technology design and development. The 465 
materials used in the manufacture of the IMPACT sensor have previously undergone 466 
extensive biocompatibility in both normal and diseased tissues, with results indicating that 467 
the materials are well tolerated with a minimal FBR elicited when implanted in vivo. These 468 
results have led to the use of these materials in a variety of medical devices (15). Although 469 
the FBR was not evaluated in this study, it is possible that acute inflammation could occur 470 
through either intestinal manipulation, placement of the sensor on the intestinal serosal 471 
surface or through the use of tissue glue to secure the sensor in place. In order to minimise 472 
these potential effects, the intestine was handled as little as possible and the glue was 473 
placed away from the sensors sensing area. Chronic inflammation was also not evaluated in 474 
this study largely due to the short-term nature of the experiments; however, we anticipate 475 
that in a clinical situation the effects from chronic inflammation may not be a significant 476 
issue. Fibrous reactions that occur around implantable devices occur mainly during the 477 
chronic inflammatory phase (5-21 days post implantation) (1); as the majority of 478 
anastomotic leaks occur within the first 8 days post-surgery (18) the use of a long-term 479 
implantable device is unlikely to be needed, this situation would reduce concerns regarding 480 
the impact that chronic inflammation can have on sensor functionality. 481 
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One potential limitation to these experiments is that both the SMA occlusion technique and 482 
alterations in FiO2 (0.1 to 1.0) represent extreme experimental insults that may not 483 
accurately represent physiological ischaemic and hypoxaemic changes that occur following 484 
intestinal surgery. However, the primary aim of this study was to validate the ability of the 485 
IMPACT sensor to measure dynamic changes in intestinal ptO2; our results provide 486 
justification to progress validation experiments into more complex large animal anastomotic 487 
leak models. Pigs are regarded as excellent gastrointestinal translational models as they 488 
offer similarities in size, anatomy and physiology to that of humans and a porcine rectal 489 
anastomotic leak model has been described in the literature (43). Development of this 490 
porcine model could be performed for use in future experiments with the IMPACT O2 491 
sensor. These next phase experiments would investigate the sensors potential to monitor 492 
intestinal ptO2 in normal physiological conditions and in those situations associated with an 493 
anastomotic leak and assess the suitability of the sensors for surgical implantation. Medium 494 
to long-term duration experiments would also allow the FBR and its effects on sensor 495 
functionality to be investigated. The use of this model would also allow evaluation of 496 
feasibility of placing multiple sensors, not only at the anastomotic site, but also at multiple 497 
sites along the gastrointestinal tract. These studies will elucidate the potential of the 498 
sensors to be used in human patients for the early detection of anastomotic leakage and the 499 
hypoperfusion that may precede it. Experiments will also provide clinical, haematological 500 
and biochemical indicators of anastomotic leakage and the development of septic 501 
peritonitis. 502 
For the IMPACT O2 sensors to be used clinically for resection and anastomotic applications 503 
investigations will need to be carried out to determine how these sensors could be placed 504 
intra-operatively, at the anastomotic site, or at multiple sites along the gastrointestinal tract 505 
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so that they remain in situ and are able to measure post-operative intestinal ptO2. Potential 506 
solutions would include their use akin to a surgical drain or through sensor incorporation 507 
into surgical staples. Drains are used commonly in anastomotic surgery (20, 33, 35) and are 508 
not associated with any significant complications. Placed in the region of the anastomotic 509 
site, the drains exit the abdominal cavity through a skin incision which are then connected 510 
to external drainage bags and are easily removed when no longer required. Drains have 511 
been used to obtain post-operative peritoneal samples from anastomotic sites for 512 
measuring bacterial colonisation, cytokines (12) and metabolites (32) that might serve as 513 
indicators of early anastomotic leakage. We propose that designing the IMPACT O2 sensor in 514 
a similar manner to a surgical drain would allow easy clinical use. The sensors, along with an 515 
electrical lead (similar in design to the current IMPACT O2 sensor and lead wire), could be 516 
positioned on the intestine next to the anastomosis site at the time of surgery. The electrical 517 
lead would then pass out through the skin, like that of a surgical drain, allowing the sensor 518 
to be connected to the end-of-bed monitor, providing post-operative, real-time data on 519 
peri-anastomotic intestinal ptO2 levels. The sensors could then be removed, in the same 520 
way as a surgical drain would be, when no longer required. The advantage of this approach 521 
would be that the IMPACT O2 sensor would not require significant further development. 522 
Incorporation of IMPACT O2 sensors into staples would have the advantage that peri-523 
anastomotic ptO2 could be measured around the entire circumference of the intestine, thus 524 
providing detailed spatial information. However, further technological development of the 525 
sensor through miniaturisation and the development of wireless technology would be 526 
required in order to achieve sensor integration into surgical staples. If these engineering 527 
advancements could be achieved it would provide opportunities for placing multiple sensors 528 
throughout the gastrointestinal tract, this concept could be utilised for measuring mucosal 529 
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ptO2 for other intestinal conditions where microenvironmental mucosal hypoxia can 530 
influence disease outcomes such as chronic intestinal inflammation (42). 531 
Conclusion 532 
Using our developed rodent model of small intestinal ischaemia and hypoxaemia, we 533 
successfully demonstrated that the IMPACT O2 sensor can detect dynamic changes in 534 
intestinal oxygenation through ischaemic insults, alterations in FiO2 and euthanasia. These 535 
miniaturised sensors have significant advantages over Clark O2 sensors previously used in 536 
the literature as they have the potential be used during surgery and be left in situ following 537 
surgery to provide post-operative, minimally-invasive, continuous, real-time data regarding 538 
transitory changes in tissue ptO2. This novel method of monitoring tissue perfusion could, 539 
for example, detect early peri-anastomotic tissue hypoxia and identify patients that may 540 
benefit from treatments to improve local oxygenation and prevent a leak. The sensors 541 
capability to detect dynamic intestinal oxygenation changes could also be used to assess 542 
treatment responses and, when combined with information gained from conventional 543 
monitoring systems, would help provide a more accurate assessment of the patient’s 544 
condition. We expect that this type of visceral surface oximetry will prove clinically useful in 545 
the evaluation of bowel perfusion and may also be a powerful tool in many other clinical 546 
and research applications where measurement of organ perfusion is required, for example 547 
in transplant surgery, chronic intestinal ischaemia and inflammation, plastic surgery and 548 
brain injury. 549 
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Figure and Table Legends 685 
 686 
Figure 1. Intra-operative photographs depicting placement of central venous (jugular) and 687 
arterial (carotid) lines. a) A 2 cm ventral cervical skin incision is made. b&c) Cervical 688 
dissection is performed for identification and mobilisation of the right jugular vein. d) One 689 
untied suture is placed distally around the jugular vein and a second is placed proximally 690 
and tied securely, leaving approximately 1 cm of vein between the 2 sutures. e) A venotomy 691 
is created just distal to the proximal suture; the cannula is inserted and advanced into the 692 
vein approximately 2-3 cm before tying the distal suture around the vein and cannula. f) 693 
Cervical dissection is performed for identification of the left carotid artery and its isolation 694 
from the vagus nerve. g) One untied suture is placed distally around the carotid artery and a 695 
second is placed proximally and tied securely leaving approximately 1.5 cm of artery 696 
between the 2 sutures. A small clamp is added just proximal to the distal suture before 697 
placing a third untied suture. h) An arteriotomy is created between the 2 sutures and the 698 
cannula is inserted and advanced up to the clamp. i) The third suture is tied loosely over the 699 
cannula and the clamp is removed. j) The cannula is advanced a further 2 cm before tying 700 
the distal suture around the artery and cannula. Both vessels were cannulated using 0.96 701 
mm outside diameter PVC tubing (Scientific Commodities Inc., Lake Havasu City, AZ, USA) 702 
and secured in place with 5-0 silk (Ethicon, UK). 703 
 704 
Figure 2. Outline of experimental protocols and interventions. Protocol 1: Control animals 705 
with no interventions. Protocol 2: Superior mesenteric artery occlusion. Protocol 3: 706 
Alterations in FiO2, haemorrhage and autotransfusion (resuscitation). Instrumentation 707 
encompassed: anaesthesia induction, surgical preparation, placement of arterial and venous 708 
lines and celiotomy. The sensor was placed on the serosal surface of the small intestine 709 
approximately half way through the stabilisation period. Continuous sensor readings were 710 
commenced following the achievement of stable baseline physiological variables and 711 
continued for 15 min following confirmation of death post-euthanasia. 712 
 713 
Figure 3. Sensor picture and intra-operative photographs depicting intestinal placement of 714 
the sensor. a) Macroscopic image of the IMPACT miniaturised O2 sensor. b) Intra-operative 715 
sensor placement on the serosal surface of a section of small intestine. 716 
 717 
Figure 4. Sensor readings and physiological data obtained from control animals (Protocol 718 
1). a) Current generated at the working electrode of the sensor during continuous sensor 719 
readings over a period of 165 min; results show mean current readings from the final 5 min 720 
of each 15 min period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 721 
expressed as mean ± SEM, n=3, p=0.7244). b) Physiological data obtained throughout the 722 
experimental period (Hb: haemoglobin; ABE: arterial base excess; SaO2: haemoglobin O2 723 
saturation; PaO2: arterial O2 partial pressure; PaCO2: arterial CO2 partial pressure; CT: core 724 
temperature; RR: respiratory rate; HR: heart rate). 725 
 726 
Figure 5. Intra-operative photographs and sensor readings during temporary superior 727 
mesenteric artery occlusion (Protocol 2). ai) Identification of the SMA originating from the 728 
left side of the aorta at the level of the right renal vein joining the caudal vena cava; the 729 
vessel is robust and can withstand the manipulation required for isolation from its 730 
surrounding tissue and associated vein. aii) A Bulldog clamp was placed across the SMA for 731 
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temporary occlusion. Note the intestinal pallor that was immediately evident upon 732 
occlusion. aiii) Following removal of the Bulldog clamp and reinstatement of blood flow, a 733 
hyperaemic flush was evident to the intestines. b) Representative graph showing current 734 
generated at the working electrode of the sensor during continuous sensor readings over a 735 
period of 70 min. Three cycles of 5 min occlusion followed by 10 min of reperfusion were 736 
performed in each animal before euthanasia. c) Combined analysis comparing current 737 
generated at the working electrode of the sensor during periods of SMA occlusion and 738 
intestinal reperfusion; results show mean current readings of the final 3 min of each 739 
occlusion period and final 5 min of each reperfusion period (one-way ANOVA with Holm-740 
Šídák multiple comparisons test; data expressed as mean ± SEM, n=4, **p≤0.01). 741 
 742 
Figure 6. Sensor readings and physiological data obtained from assessing intestinal tissue 743 
oxygenation following changes in inspired O2 concentrations (Protocol 3A). a) 744 
Representative graph showing current generated at the working electrode of the sensor 745 
during continuous sensor readings over a period of 150 min. 15 min blocks of each FiO2 746 
challenge were performed before beginning the removal of 30% of the circulating blood 747 
volume. b) Combined analysis comparing current generated at the working electrode of the 748 
sensor during each FiO2 challenge; results show mean current readings of the final 5 min of 749 
each 15 min period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 750 
expressed as mean ± SEM, n=5, ****p≤0.0001; *p≤0.05). c&d) Arterial O2 partial pressure, 751 
total haemoglobin and haemoglobin O2 saturation measured at end of each FiO2 challenge. 752 
 753 
Figure 7. Sensor readings and physiological data obtained from assessing intestinal tissue 754 
oxygenation following progressive haemorrhage and autotransfusion (Protocol 3B). a) 755 
Combined analysis comparing current generated at the working electrode of the sensor 756 
during the preceding 15 min baseline period at 21% O2 and the subsequent 2 cycles of 757 
removal of 15% circulating blood volume followed by autotransfusion; results show mean 758 
current readings of the final 5 min of each period (one-way ANOVA with Holm-Šídák’s 759 
multiple comparisons test; data expressed as mean ± SEM, n=5). b&c) Mean arterial blood 760 
pressure, heart rate, total haemoglobin and haemoglobin O2 saturation measured at end of 761 
each of intervention period (haem: haemorrhage; Resus: autotransfusion resuscitation). 762 
 763 
Table I. Current readings generated during each superior mesenteric artery occlusion and 764 
reperfusion period and euthanasia (n=4; mean ± SEM). 765 
 766 
Table II. Current readings generated during each FiO2 challenge and euthanasia (n=5; mean 767 
± SEM). 768 
 769 
Table III. Current readings generated during 21% FiO2, each haemorrhage procedure and 770 
autotransfusion (n=5; mean ± SEM). 771 
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